Indian Salbutamol Exporters: Complete Supplier Ranking with Market Share — 602 Manufacturers (2026) — TransData Nexus

Q: Who is the largest salbutamol supplier from India?

CIPLA LIMITED is the largest salbutamol exporter from India with a 67.4% market share and export value of $100.3M.

Q: How many salbutamol suppliers are there in India?

There are 602 active salbutamol exporters in India, collectively shipping $148.8M worth of salbutamol across 14,359 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top salbutamol suppliers from India?

The top 5 salbutamol suppliers from India — CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, AHLCON PARENTERALS (INDIA) LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — together control 79.6% of total salbutamol export value from India.

Suresh Sormare

Salbutamol

India Pharmaceutical Trade Intelligence

$148.8M602 Suppliers164 CountriesHS 30049099

ExportsIndia → BRAZIL25.8%India → SOUTH AFRICA24.1%

ImportsIRELAND → India$158.9K UNITED KINGDOM → India$12.5K

#1 Supplier: CIPLA LIMITED

Salbutamol Suppliers from India (2026) — 602 Exporters, $148.8M Market | TransData Nexus | TransData Nexus

Who Exports Salbutamol from India — 602 Suppliers Behind a $148.8M Market

India's salbutamol export market is supplied by 602 active exporters who collectively shipped $148.8M across 14,359 shipments. CIPLA LIMITED leads with a 67.4% market share, followed by GLENMARK PHARMACEUTICALS LIMITED and AHLCON PARENTERALS (INDIA) LIMITED. The top 5 suppliers together control 79.6% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Salbutamol Suppliers & Exporters — 602 manufacturers, $148.8M export market, top destinations and formulations — Salbutamol supplier data — 602 exporters · $148.8M market · 14,359 shipmentsTransData Nexus · Indian Customs Data

Top Salbutamol Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading salbutamol exporter from India, holding a 67.4% share of the $148.8M market across 14,359 shipments from 602 exporters. The top 5 suppliers — CIPLA LIMITED, GLENMARK PHARMACEUTICALS LIMITED, AHLCON PARENTERALS (INDIA) LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — collectively control 79.6% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (67.4%), GLENMARK PHARMACEUTICALS LIMITED (3.9%), AHLCON PARENTERALS (INDIA) LIMITED (3.3%), MEDISPRAY LABORATORIES PRIVATE LIMITED (3.3%), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (1.7%).

Top Salbutamol Exporters from India

Ranked by export value · 602 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Salbutamol Exporters from India — Ranked by Export Value. 602 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Salbutamol — Export Intelligence Video

Visual overview of India's salbutamol supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's salbutamol pharmaceutical supplier landscape — $148.8M in total trade, 602 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Salbutamol exporters

Certification and compliance status for top Salbutamol suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes	Yes	Multiple	Cipla is a leading Indian pharmaceutical company with multiple FDA approvals and
GLENMARK PHARMACEUTICALS LIMITED	Warning Letter, July 2025	Yes	Yes	Multiple	Received FDA warning letter in July 2025 for Madhya Pradesh facility; holds WHO-
EMCURE PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Emcure has FDA approvals and holds WHO-GMP and EU-GMP certifications.
MACLEODS PHARMACEUTICALS LTD	Approved	Yes	Yes	Multiple	Macleods Pharmaceuticals is FDA-approved and holds WHO-GMP and EU-GMP certificat
FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED	Not Listed	Yes	Yes	Not verified	Fourrts holds WHO-GMP and EU-GMP certifications; FDA status not listed.
ZYDUS LIFESCIENCES LIMITED	Approved	Yes	Yes	Multiple	Zydus Lifesciences has FDA approvals and holds WHO-GMP and EU-GMP certifications
MICRO LABS LIMITED	Approved	Yes	Yes	Multiple	Micro Labs is FDA-approved and holds WHO-GMP and EU-GMP certifications.
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED	Warning Letter, October 2	Yes	Yes	Not verified	Received FDA warning letter in October 2023 for Tamil Nadu facility; holds WHO-G

TransData Nexus reviewed the regulatory standing of 8 leading Salbutamol exporters from India. 5 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Salbutamol sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a central hub for the production of active pharmaceutical ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in research and development, particularly in APIs and biologics.

The Telangana government's initiative to develop "Pharma City" aims to create the world's largest integrated pharmaceutical cluster, consolidating manufacturing, research, and support services. This development is expected to bolster Hyderabad's position as a leading center for API production, including Salbutamol.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's well-established infrastructure, including ports and transportation networks, facilitates efficient manufacturing and distribution of pharmaceutical products.

The state's emphasis on regulatory compliance and quality standards makes it a preferred location for the production of finished dosage forms, including Salbutamol tablets and inhalers. The presence of a skilled workforce and supportive government policies further enhance the region's attractiveness for pharmaceutical manufacturing.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Salbutamol exporters from India

April 2024

Acquisition

Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care business

Cipla Limited acquired Ivia Beaute Pvt Ltd's cosmetics and personal care distribution and marketing business for ₹130 crore. - IMPACT: This acquisition is not expected to directly impact Cipla's Salbutamol exports.

Impact: This acquisition is not expected to directly impact Cipla's Salbutamol exports.

August 2022

Investment

Cipla Limited — Cipla acquires 21.05% stake in Achira Labs

Cipla Limited acquired a 21.05% stake in Achira Labs Private Limited, a company specializing in medical diagnostics. - IMPACT: This investment is not anticipated to have a direct effect on Cipla's Salbutamol export activities.

Impact: This investment is not anticipated to have a direct effect on Cipla's Salbutamol export activities.

August 2022

Joint Venture

Common Questions — Salbutamol Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which salbutamol supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 2,828 recorded shipments worth $100.3M. GLENMARK PHARMACEUTICALS LIMITED (298 shipments) and AHLCON PARENTERALS (INDIA) LIMITED (117 shipments) are also established high-volume exporters.

Q How many salbutamol manufacturers are there in India?

India has 602 active salbutamol exporters with a combined export market of $148.8M across 14,359 shipments to 164 countries. The top 5 suppliers hold 79.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for salbutamol from India?

Average FOB unit price: $2.56 per unit, ranging from $0.00 to $11607.35. Average shipment value: $10.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Salbutamol

Salbutamol

Who Exports Salbutamol from India — 602 Suppliers Behind a $148.8M Market

Top Salbutamol Exporters from India — Ranked by Export Value

Top Salbutamol Exporters from India

Related Analysis

Need Details?

Salbutamol — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care business

Cipla Limited — Cipla acquires 21.05% stake in Achira Labs

Common Questions — Salbutamol Suppliers from India

Q Which salbutamol supplier from India is the most reliable for bulk orders?

Q How many salbutamol manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for salbutamol from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cipla Limited — Cipla forms joint venture Aspergen Inc.

Analysis Methodology